Circulating microRNAs predict biochemical recurrence in prostate cancer patients

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Circulating microRNAs (miRNAs) are increasingly recognized as potential biomarkers for prostate cancer (PCa).
• This study explores the utility of serum miRNAs for predicting prognosis and guiding treatment decisions in PCa patients.

Purpose of the Study:

• To investigate the role of circulating microRNAs in predicting biochemical recurrence (BCR) and disease progression after radical prostatectomy (RP).
• To evaluate the prognostic value of specific miRNAs in intermediate-risk prostate cancer.

Main Methods:

• Serum miRNAs were profiled using high-throughput qRT-PCR in patients with rapid BCR versus no recurrence.
• Recurrence-associated miRNAs were validated in a cohort of 70 patients with Gleason 7 PCa, and their expression was examined in tumor tissue.

Main Results:

• Three miRNAs (miR-141, miR-146b-3p, miR-194) were elevated in patients with subsequent BCR.
• miR-146b-3p and miR-194 levels correlated with disease progression in the validation cohort.
• miR-146b-3p provided prognostic information beyond standard parameters; miR-194 was elevated in metastases and associated with poor prognosis in primary tumors.

Conclusions:

• Circulating miRNAs measured at the time of RP could enhance current prognostic tools.
• These miRNAs may aid in predicting future disease progression in men with intermediate-risk prostate cancer.
• Further research can integrate miRNA analysis into routine PCa management for improved patient outcomes.